Glycopeptides: Clinical Trials

5 trials of Glycopeptides, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown. 1 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 11Unknown 1
Phase 21Unknown 1
Phase 31Unknown 1
Phase 41Completed 1

Follow Glycopeptides: new trials by email Literature Review of Glycopeptides trials Research Report on Glycopeptides

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Initial Clostridium Difficile Infection
FMT, Vancomycin - Clostridium Difficile Infection
Not applicableCompletedUniversidad Autonoma de Nuevo Leon102015-02-012017-04-18
Effect Study of Tigecycline to Treat Severe Sepsis and Septic Shock
glycopeptide plus carbapenem, Haizheng Li Xing ® plus tazocin ® - Abdominal Infection
Phase 2 / Phase 3UnknownTianjin Medical University Cancer Institute and Hospital1002014-05-012014-07-16
The Study of Biodistribution and Dosimetry of 99mTc-Glycopeptide(99mTc-GP) in Patients With Breast Cancer
Radiolabeled (99mTc) GP (Glycopeptide) - Breast Cancer
Phase 1UnknownSeeCure LLC92010-06-012014-07-30
Teicoplanin Prophylaxis for Total Hip or Knee Arthroplasty
Teicoplanin, β-lactams or ciprofloxacin - Total Hip and Knee Arthroplasties
Phase 4CompletedUniversity of Athens6162004-08-012008-07-21
Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients
piperacillin-tazobactam, glycopeptide - Hematological Malignancy, Leukemia
CompletedWyeth is now a wholly owned subsidiary of Pfizer8012001-07-012009-11-16

Conditions studied

Anemia, Refractory, with Excess of Blasts (1)  ·  Breast Neoplasms (1)  ·  Clostridium Infections (1)  ·  Hematologic Neoplasms (1)  ·  Intraabdominal Infections (1)  ·  Leukemia (1)  ·  Lymphoma (1)  ·  Neoplasms, Plasma Cell (1)  ·  Surgical Wound Infection (1)

Sponsors

SeeCure LLC (1)  ·  Tianjin Medical University Cancer Institute and Hospital (1)  ·  Universidad Autonoma de Nuevo Leon (1)  ·  University of Athens (1)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (1)

Countries

China (1)  ·  Greece (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Amyntas Varvaroussis, MD (1)  ·  Antonios Papadopoulos, MD, PhD (1)  ·  Helen Giamarellou, MD, PhD (1)  ·  Panagiotis Papadelis, MD (1)  ·  Tejal Patel, M.D. (1)  ·  Vassilios Nikolaidis, MD (1)  ·  Wang Donghao, Chief (1)

Results publications

PMID 17359318, PMID 23772043